FDA Inspection 1200029 — H. Lee Moffitt Cancer Center & Research Institute

H. Lee Moffitt Cancer Center & Research Institute — FEI 1038768

The FDA completed an inspection of H. Lee Moffitt Cancer Center & Research Institute on February 7, 2023 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 7, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tampa, FL (United States)